Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 09 2022 - 4:13PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2022
Commission
File Number: 001-40212
Connect
Biopharma Holdings Limited
(Translation of registrants name into English)
Science and Technology Park
East R&D Building, 3rd Floor
6 Beijing West Road, Taicang
Jiangsu Province, China 215400
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On May 4, 2022, Selwyn Ho, MB BS, informed Connect Biopharma Holdings Limited (the Company) of his intention to resign as Chief
Business Officer of the Company to pursue a new opportunity. His last day at the Company will be June 30, 2022.
This report on Form 6-K shall be deemed to be incorporated by reference into the registration statements on Form F-3 and S-8 (Registration Nos. 333-264340 and 333-254524, respectively) of the Company and to be a part thereof from the date on which this report is furnished, to the extent not superseded by documents or
reports subsequently filed or furnished.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
Dated: May 9, 2022 |
|
|
|
CONNECT BIOPHARMA HOLDINGS LIMITED |
|
|
|
|
|
By |
|
/s/ Steven Chan |
|
|
|
|
Name: |
|
Steven Chan |
|
|
|
|
Title: |
|
Chief Financial Officer |
Connect Biopharma (NASDAQ:CNTB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Connect Biopharma (NASDAQ:CNTB)
Historical Stock Chart
From Sep 2023 to Sep 2024